Sanara MedTech Inc. SMTI Equity in earnings (losses) of equity method investees

Equity in earnings (losses) of equity method investees at other companies

Energy TransferET

$110M+19.6%

Ameriprise FinancialAMP

-$6M+53.8%

The Travelers CompaniesTRV

$23M-56.6%

NucorNUE

$7M+75.0%

ChubbCB

$157M+91.5%

Elevance HealthELV

$305M+142%

Other financials

Income statement

See full

Revenue$27.8M+18.6%

Gross profit$25.9M+19.8%

Operating income$2.6M+221%

Net income$459.0K+113%

EPS (diluted)$0.05+112%

Balance sheet

See full

Cash & equivalents$13.6M-34.3%

Total debt$48.4M+8.2%

Total equity$7.0M-80.8%

Total assets$69.3M-28.1%

Cash flow

See full

Operating cash flow-$2.5M-23.3%

CapEx$43.8K-97.5%

Free cash flow-$2.5M+32.6%

Valuation

See full

Market cap$216.18M-9.7%

Enterprise value$250.95M-6.5%

P/S2×-0.5×

Profitability

See full

Gross margin92.9%+1.8pp

Operating margin6.1%+5.1pp

Net margin-31.2%-93.4pp

FCF margin-9.8%-3.5pp

Returns & leverage

See full

Return on equity-153.7%-199pp

Debt / equity6.9×+5.7×

Current ratio2.3×-0.5×

Where this comes from

Reported directly by Sanara MedTech Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.

The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sanara MedTech Inc.'s equity in earnings (losses) of equity method investees.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sanara MedTech Inc.'s equity in earnings (losses) of equity method investees?: Sanara MedTech Inc. (SMTI) reported equity in earnings (losses) of equity method investees of -$462.51K in Q1 2026.
How has Sanara MedTech Inc.'s equity in earnings (losses) of equity method investees changed year-over-year?: Sanara MedTech Inc.'s equity in earnings (losses) of equity method investees decreased by 222.1% year-over-year, from -$143.61K to -$462.51K.